Sunday, 25 Oct 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Company
Deals
MindRank Ltd Receives FDA Clearance for MRANK-106 Clinical Study in Solid Tumors
March 12, 2025
Company
Drug
AIM Vaccine Co. Ltd Announces Market Filing for Innovative Serum-Free Rabies Vaccine
March 12, 2025
Company
Deals
TowardPi Medical Secures RMB500 Million in Series E Round for Ophthalmic Equipment Expansion
March 12, 2025
Company
Deals
WuXi XDC and AbTis Partner to Advance Antibody-Drug Conjugate Innovation
March 12, 2025
Company
Drug
Ascletis Pharma’s ASC47 Shows Positive Results in Phase Ib Study for Weight Loss
March 12, 2025
Company
Drug
AstraZeneca’s Imfinzi Approved by NMPA for Early-Stage NSCLC Treatment
March 11, 2025
Company
Medical Device
Huihe Healthcare’s K-Clip Wins Chinese Approval for Tricuspid Regurgitation Treatment
March 11, 2025
Company
Harbour BioMed Appoints Michael D. Patten as Chief Strategy Officer to Lead Global Growth
March 11, 2025
Company
Deals
Genmab’s HexaBody-CD38 Clinical Development Halted After J&J Opt-Out
March 11, 2025
Company
Drug
Sichuan Kelun-Biotech’s Sacituzumab Tirumotecan Wins New NMPA Approval for NSCLC
March 11, 2025
Company
Illumina Responds to Chinese MOFCOM Notice Amid Sequencing Instrument Export Ban
March 11, 2025
Company
Drug
Huadong Medicine Seeks Regular Approval for Elahere in Ovarian Cancer Treatment
March 11, 2025
1
2
…
20
21
22
23
24
…
31
32
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?
